Collaboration between Burnham Institute for Medical Research and the Sarah W Stedman Nutrition and Metabolism Center

Agreement calls for cell research and patents sharing

Tilidine with Naloxone, to address moderate to severe pain, such as cancer pain and post-operative pains

Initiates second of two randomised, double-blind non-small-cell lung cancer trials in Canada

Botulinum Toxin Type -A, an anti-ageing medicine, is used in the correction of facial wrinkles and hyperhidrosis

Byetta, an FDA-approved twice-daily injection form of exenatide

For the development of long-acting EPO analog for chronic kidney disease

Available in pink and purple for a limited time

Analog to improve glycemic control in adults with type 2 diabetes

For emergency compounding of oral suspension of Tamiflu capsules

Edluar sublingual tablets contain zolpidem tartrate and have a pharmacokinetic profile

Walter Colasante, as vice president and Sophie Murdoch, as director

To assess CNS 7056, short-acting intravenous anesthetic/sedative in patients undergoing endoscopy

Bayer Schering Pharma filed IND application for MN-IC to trigger milestone payment

To provide general formulation development and clinical material manufacturing

Company expects to begin arimoclomol phase IIb clinical trial by fourth quarter of this year

Unanimous agreement for Sinovac's H1N1 vaccine

Acurox, for the relief of moderate-to-severe pain

US Bankruptcy Court approved the rights for North America and certain countries in Europe

CYT387, to treat various haematological disorders